Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.
Revenue from operations for the half year was Rs. 178.5 crore, declined by 23% whereas net profit for the half year was Rs. 16.9 crore, declined by 70%
The company has reported total income of Rs. 703.3 crores during the period ended September 30, 2022
The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated